Studies related to Fibrinogen and Red Clover Extract

Modest Protective Effects Of Isoflavones From A Red Clover-derived Dietary Supplement On Cardiovascular Disease Risk Factors In Perimenopausal Women, And Evidence Of An Interaction With ApoE Genotype In 49-65 Year-old Women

Effect None
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 177
Gender Female
Age Range 45-64
Body Types Overweight
Notes for this study:
43.5mg of red clover isoflavones daily for one year has failed to significantly improve cardiovascular risk factors, and when controlling for the ApoE genotype there was a stronger trend for inprovement that still failed to reach statistical significance.

Effects Of Dietary Supplementation With Isoflavones From Red Clover On Ambulatory Blood Pressure And Endothelial Function In Postmenopausal Type 2 Diabetes

Effect None
Trial Design Double blind
Trial Length 2-4 Weeks
Number of Subjects 16
Gender Female
Age Range 45-64, 65+
Body Types Obese, Overweight
Notes for this study:
Oral supplementation of 50mg isoflavones (mostly formononetin) from red clover for four weeks in postmenopausal women with type II diabetics was able to improve basal blood flow as assessed by forearm resistance (L-NMMA treatment) and reduced blood pressure by 8mmHg systolic and 4.3mmHg diastolic. No statistically significant changes were noted elsewhere.